Hologic, Inc. (NasdaqGS:HOLX) announces a share repurchase program. Under the program, the company will repurchase up to $1,000 million worth of its outstanding common stock. The repurchase plan is valid for 5 years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.14 USD | -0.81% | -1.83% | +5.16% |
May. 09 | Argus Adjusts Price Target on Hologic to $95 From $89 | MT |
May. 06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.16% | 17.54B | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. announces an Equity Buyback for $1,000 million worth of its shares.